ASX ANNOUNCEMENT 4 November 2026 $913k Entitlement Offer Complete; Firm Commitments Received to Raise a Further $550k via Placement Melbourne, Australia; 4 November 2026: Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), confirms that it has raised a total of...
Commitments received for further $550k via placement
Filed with ASX · · 1 page · English
Summary by 6ix AI
Cynata Therapeutics Limited has announced the completion of an entitlement offer that raised a total amount before costs, along with firm commitments for a placement to raise additional funds. The placement involves issuing new shares at the same price as the entitlement offer, with options attached to the shares. Proceeds from the placement will enhance the company's ability to pursue new asset opportunities and cover offer costs. Shareholder approval will be sought for the placement and associated options at an upcoming general meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Appendix 3Y-Ms Janine Rolfe
- Appendix 3Y-Dr Kilian Kelly
- Appendix 3Y-Dr Geoffrey Brooke
- Notification regarding unquoted securities - CYP
- Application for quotation of securities - CYP
Later from Cynata Therapeutics
All Cynata Therapeutics news releasesFollow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics